A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing drug-resistant tuberculosis (TB), and almost halved adults’ and children’s risk of developing multidrug-resistant TB.
Study finds strategies to minimize acne recurrence after taking medication for severe acne
Isotretinoin, commonly referred to as Accutane, is the only approved medical treatment capable of inducing long-term remission of severe acne. Although highly effective, some individuals experience recurrence of acne after a course of treatment.
Scientists identify new epigenetic approach to target colorectal cancer
A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new study from researchers at the Johns Hopkins Kimmel Cancer Center and the Chinese Academy of Sciences.
Medical imaging AI analyzes 30k data points per pixel in cancer search
A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue—some as small as 400 square micrometers, equivalent to the width of five human hairs.
Drinking alcohol is linked to health risks, says report
A new federal report warns that drinking alcohol could raise your risk of dying early.
Changes in microbiome can predict risk for sexually transmitted disease in women
Women who develop bacterial vaginosis (BV) often later acquire chlamydia, a common and potentially serious sexually transmitted bacterial infection. Now, researchers at Albert Einstein College of Medicine, Roswell Park Comprehensive Cancer Center, and the Icahn School of Medicine at Mount Sinai have found that BV actually consists of two subtypes—one of which significantly increases the risk of developing chlamydia infections.
Xenon gas shows promise in Alzheimer’s treatment, leading to clinical trial
Most treatments being pursued today to protect against Alzheimer’s disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and Washington University School of Medicine in St. Louis points to a novel—and noble—approach: using Xenon gas.
Comprehensive blood analysis offers insight into biology and risk factors of childhood obesity
A cutting-edge molecular approach provides a detailed picture of the biological pathways associated with childhood obesity and metabolic dysfunction, and identifies environmental risk factors during early life. The study, led by the Barcelona Institute for Global Health (ISGlobal) can help to develop strategies to prevent childhood obesity and its long-term health effects.
Vaccination does not impact long COVID neurological symptoms
Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postacute sequelae of SARS-CoV-2 infection, according to a study published online Jan. 7 in Brain Communications.
UK government bans ‘zombie drug’ xylazine
The UK government on Wednesday banned the flesh-rotting so-called zombie drug xylazine as it tries to tackle deaths from narcotics and crack down on criminal gangs.